Identification of Optimal Donor-Recipient Combinations Among Human Immunodeficiency Virus (HIV)-Positive Kidney Transplant Recipients

被引:8
作者
Locke, J. E. [1 ]
Shelton, B. A. [1 ]
Reed, R. D. [1 ]
MacLennan, P. A. [1 ]
Mehta, S. [1 ]
Sawinski, D. [2 ]
Segev, D. L. [3 ]
机构
[1] Univ Alabama Birmingham, Comprehens Transplant Inst, Birmingham, AL 35233 USA
[2] Univ Penn, Comprehens Transplant Ctr, Philadelphia, PA 19104 USA
[3] Johns Hopkins Univ, Baltimore, MD USA
基金
美国国家卫生研究院;
关键词
clinical research; practice; health services and outcomes research; infectious disease; kidney transplantation; nephrology; immune deficiency; infection and infectious agents; viral: human immunodeficiency virus (HIV); acquired immunodeficiency syndrome (AIDS); viral: hepatitis C; RENAL-TRANSPLANTATION; ACUTE REJECTION; HIV; IMMUNOSUPPRESSION; SURVIVAL; OUTCOMES; LIVER;
D O I
10.1111/ajt.13847
中图分类号
R61 [外科手术学];
学科分类号
摘要
For some patient subgroups, human immunodeficiency virus (HIV) infection has been associated with worse outcomes after kidney transplantation (KT); potentially modifiable factors may be responsible. The study goal was to identify factors that predict a higher risk of graft loss among HIV-positive KT recipients compared with a similar transplant among HIV-negative recipients. In this study, 82 762 deceased donor KT recipients (HIV positive: 526; HIV negative: 82 236) reported to the Scientific Registry of Transplant Recipients (SRTR) (2001-2013) were studied by interaction term analysis. Compared to HIV-negative recipients, the hepatitis C virus (HCV) amplified risk 2.72-fold among HIV-positive KT recipients (adjusted hazard ratio [aHR]: 2.72, 95% confidence interval [CI]: 1.75-4.22, p < 0.001). Forty-three percent of the excess risk was attributable to the interaction between HIV and HCV (attributable proportion of risk due to the interaction [AP]: 0.43, 95% CI: 0.23-0.63, p = 0.02). Among HIV-positive recipients with more than three HLA mismatches (MMs), risk was amplified 1.80-fold compared to HIV-negative (aHR: 1.80, 95% CI: 1.31-2.47, p < 0.001); 42% of the excess risk was attributable to the interaction between HIV and more than three HLA MMs (AP: 0.42, 95% CI: 0.24-0.60, p = 0.01). High-HIV-risk (HIV-positive/HCV-positive HLAwith more than three MMs) recipients had a 3.86-fold increased risk compared to low-HIV-risk (HIV-positive/HCV-negative HLA with three or fewer MMs)) recipients (aHR: 3.86, 95% CI: 2.37-6.30, p < 0.001). Avoidance of more than three HLA MMs in HIV-positive KT recipients, particularly among coinfected patients, may mitigate the increased risk of graft loss associated with HIV infection. Avoidance of HLA mismatches in HIV-infected kidney transplant recipients, particularly among those coinfected with hepatitis C, may mitigate the increased risk of graft loss associated with HIV infection.
引用
收藏
页码:2377 / 2383
页数:7
相关论文
共 39 条
  • [31] Antiretroviral and Immunosuppressive Drug-Drug Interactions in Human Immunodeficiency Virus-Infected Liver and Kidney Transplant Recipients
    Marfo, K.
    Greenstein, S.
    TRANSPLANTATION PROCEEDINGS, 2009, 41 (09) : 3796 - 3799
  • [32] Risk of Oral Tongue Cancer Among Immunocompromised Transplant Recipients and Human Immunodeficiency Virus-Infected Individuals in the United States
    Tota, Joseph E.
    Engels, Eric A.
    Madeleine, Margaret M.
    Clarke, Christina A.
    Lynch, Charles F.
    Ortiz, Ana P.
    Hernandez, Brenda Y.
    Chaturvedi, Anil K.
    CANCER, 2018, 124 (12) : 2515 - 2522
  • [33] Impact of Donor Hepatitis C Virus on Kidney Transplant Outcomes for Hepatitis C-positive Recipients in the Direct-acting Antiviral Era: Time to Revise the Kidney Donor Risk Index?
    Cannon, Robert M.
    Locke, Jayme E.
    Orandi, Babak J.
    Anderson, Douglas J.
    Davis, Eric G.
    Mackelaite, Lina
    Dave, Hitarth
    Eng, Mary
    Jones, Christopher M.
    TRANSPLANTATION, 2020, 104 (06) : 1215 - 1228
  • [34] The influence of mTOR inhibitors on the incidence of CMV infection in high-risk donor positive-recipient negative (D plus /R-) kidney transplant recipients
    Cristelli, Marina Pontello
    Esmeraldo, Ronaldo Matos
    Pinto, Cahue Motta
    Sandes-Freitas, Taina Veras
    Felipe, Claudia
    Lobo, Clarissa Ferreira
    Viana, Laila
    Mansur, Juliana
    Stopa, Suelen
    Castro Santos, Daniel Wagner
    Grenzi, Patricia Cristina
    Aguiar, Wilson Ferreira
    Tedesco-Silva, Helio
    Medina Pestana, Jose Osmar
    TRANSPLANT INFECTIOUS DISEASE, 2018, 20 (04)
  • [35] Long-term outcomes and transmission rates in hepatitis C virus-positive donor to hepatitis C virus-negative kidney transplant recipients: Analysis of United States national data
    Gupta, Gaurav
    Kang, Le
    Yu, Jonathan W.
    Limkemann, Ashley J.
    Garcia, Victoria
    Bandyopadhyay, Dipankar
    Kumar, Dhiren
    Fattah, Hasan
    Levy, Marlon
    Cotterell, Adrian H.
    Sharma, Amit
    Bhati, Chandra
    Reichman, Trevor
    King, Anne L.
    Sterling, Richard
    CLINICAL TRANSPLANTATION, 2017, 31 (10)
  • [36] Frailty Is Associated With Mortality and Incident Comorbidity Among Middle-Aged Human Immunodeficiency Virus (HIV)-Positive and HIV-Negative Participants
    Verheij, Eveline
    Kirk, Gregory D.
    Wit, Ferdinand W.
    van Zoest, Rosan A.
    Verboeket, Sebastiaan O.
    Lemkes, Bregtje A.
    van der Loeff, Maarten F. Schim
    Reiss, Peter
    JOURNAL OF INFECTIOUS DISEASES, 2020, 222 (06) : 919 - 928
  • [37] Identification of Candida dubliniensis among oral yeast isolates from an Italian population of human immunodeficiency virus-infected (HIV+) subjects
    Giammanco, GM
    Pizzo, G
    Pecorella, S
    Distefano, S
    Pecoraro, V
    Milici, ME
    ORAL MICROBIOLOGY AND IMMUNOLOGY, 2002, 17 (02): : 89 - 94
  • [38] Determinants of health-related quality of life among human immunodeficiency virus positive (HIV-positive) patients at Ahmadu Bello University teaching hospital, Zaria, Nigeria-2015
    Suleiman, Bello Abdullahi
    Yahaya, Mohammed
    Olaniyan, F. A.
    Sule, A. G.
    Sufiyan, M. B.
    BMC PUBLIC HEALTH, 2020, 20 (01)
  • [39] New blood-borne virus infections among organ transplant recipients: An Australian data-linked cohort study examining donor transmissions and other HIV, hepatitis C and hepatitis B notifications, 2000-2015
    Waller, Karen M. J.
    De La Mata, Nicole L.
    Hedley, James A.
    Rosales, Brenda M.
    O'Leary, Michael J.
    Cavazzoni, Elena
    Ramachandran, Vidiya
    Rawlinson, William D.
    Kelly, Patrick J.
    Wyburn, Kate R.
    Webster, Angela C.
    TRANSPLANT INFECTIOUS DISEASE, 2020, 22 (06)